Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulant medicines for Balloon Pulmonary Angioplasty
2024-518803-23-00Phase 4Authorised
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of edoxaban, dabigatran, rivaroxaban, apixaban, acenocoumarol and 1 more in chronic thromboembolic pulmonary hypertension (CTEPH) and Chronic Pulmonary Embolism (CPE) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Primary composite endpoint. Planned start Nov 2024; status: authorised.
02
Drugs
edoxabandabigatranrivaroxabanapixabanacenocoumarol
03
Conditions
chronic thromboembolic pulmonary hypertension (CTEPH)Chronic Pulmonary Embolism (CPE)
Beyond the preview
Go deeper on 2024-518803-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518803-23-00.